Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229236 · ClinicalTrials.gov registry record · NA
Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT06229236: Completed NA study, sponsored by Johns Hopkins University.
NCT06229236 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06229236, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
The goal of this randomized control trial is to determine if the support of a Diabetes Navigator is more effective than standard care in improving uptake and use of advanced diabetes technology among patients with type 1 diabetes.
Interventions
- BEHAVIORAL Diabetes Navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2024-02-13 |
| Est. Completion | 2025-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06229236
The ClinicalTrials.gov registry entry for NCT06229236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diabetes Navigator is the first listed.
NCT06229236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06229236 about?
NCT06229236 is a clinical study titled "Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies". The goal of this randomized control trial is to determine if the support of a Diabetes Navigator is more effective than standard care in improving uptake and use of advanced diabetes technology among patients with type 1 diabetes.
What is the current status of trial NCT06229236?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2024-02-13. Estimated completion is 2025-09-26.
What interventions are being tested in trial NCT06229236?
The interventions under investigation include: Diabetes Navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT06229236?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.